Prevention of CCl4-induced liver cirrhosis by ribbon antisense to transforming growth factor-β1

International Journal of Molecular Medicine

Volumn 21, Issue 1, 2008, Pages 33-39

  Doh, Kyung Oh ^a   Jung, Hyun Kyung ^b   Moon, Ik Jae ^b   Kang, Hyun Gu ^b   Park, Jeong Hoh ^b   Park, Jong Gu ^b,c,d  

^a Dongguk University College of Medicine   (South Korea)

^b WelGENE Inc   (South Korea)

^c Department of Medical Genetic Engineering ^*  (South Korea)

^d Keimyung University School of Medicine   (South Korea)

Author keywords

Cationic peptide; Liver cirrhosis; Ribbon antisense; Transforming growth factor 1

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANTISENSE OLIGONUCLEOTIDE; CARBON TETRACHLORIDE; COLLAGEN; MESSENGER RNA; PEPTIDE; RIBBON TYPE ANTISENSE OLIGONUCLEOTIDE; SODIUM CHLORIDE; TRANSACTIVATOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; COMPLEMENTARY RNA; DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG UPTAKE; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SURVIVAL RATE; TREATMENT DURATION; ANIMAL; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CONFORMATION; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETICS; INSTITUTE FOR CANCER RESEARCH MOUSE; LIVER; MALE; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; SURVIVAL;

ANIMALS; BASE SEQUENCE; CARBON TETRACHLORIDE; COLLAGEN; DNA; GENE EXPRESSION REGULATION; LIVER; LIVER CIRRHOSIS; MALE; MICE; MICE, INBRED ICR; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; PEPTIDES; RNA, ANTISENSE; RNA, MESSENGER; SURVIVAL ANALYSIS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 38949173501     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm.21.1.33     Document Type: Article

References (41)

1. Friedman SL: Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 275: 2247-2250, 2000.
2. Arthur MJ: Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis. Am J Physiol Gastrointest Liver Physiol 279: G245-G249, 2000.
3. Kanzler S, Lohse AW, Keil A, Henninger J, Dienes HP, Schirmacher P, Rose-John S, zum Buschenfelde KH and Blessing M: TGF-beta1 in liver fibrosis: an inducible transgenic mouse model to study liver fibrogenesis. Am J Physiol 276: G1059-G1068, 1999.
4. Bissell DM, Roulot D and George J: Transforming growth factor beta and the liver. Hepatology 34: 859-867, 2001.
5. Gressner AM, Weiskirchen R, Breitkopf K and Dooley S: Roles of TGF-beta in hepatic fibrosis. Front Biosci 7: d793-d807, 2002.
6. Knittel T, Mehde M, Kobold D, Saile B, Dinter C and Ramadori G: Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: regulation by TNF-alpha and TGF-beta1. J Hepatol 30: 48-60, 1999.
7. George J, Roulot D, Koteliansky VE and Bissell DM: In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosis. Proc Natl Acad Sci USA 96: 12719-12724, 1999.
8. Qi Z, Atsuchi N, Ooshima A, Takeshita A and Ueno H: Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat. Proc Natl Acad Sci USA 96: 2345-2349, 1999.
9. Ueno H, Sakamoto T, Nakamura T, Qi Z, Astuchi N, Takeshita A, Shimizu K and Ohashi H: A soluble transforming growth factor beta receptor expressed in muscle prevents liver fibrogenesis and dysfunction in rats. Hum Gene Ther 11: 33-42, 2000.
10. Gryaznov S, Skorski T, Cucco C, Nieborowska-Skorska M, Chiu CY, Lloyd D, Chen JK, Koziolkiewicz M and Calabretta B: Oligonucleotide N3′-->P5′ phosphoramidates as antisense agents. Nucleic Acids Res 24: 1508-1514, 1996.
11. Wagner RW, Matteucci MD, Lewis JG, Gutierrez AJ, Moulds C and Froehler BC: Antisense gene inhibition by oligonucleotides containing C-5 propyne pyrimidines. Science 260: 1510-1513, 1993.
12. Moon IJ, Choi K, Choi YK, Kim JE, Lee Y, Schreiber AD and Park JG: Potent growth inhibition of leukemic cells by novel ribbon-type antisense oligonucleotides to c-mybl. J Biol Chem 275: 4647-4653, 2000.
13. Moon IJ, Lee Y, Kwak CS, Lee JH, Choi K, Schreiber AD and Park JG: Target site search and effective inhibition of leukaemic cell growth by a covalently closed multiple anti-sense oligonucleotide to c-myb. Biochem J 346: 295-303, 2000.
14. Bajpai AK, Park JH, Moon IJ, Kang H, Lee YH, Doh KO, Suh SI, Chang BC and Park JG: Rapid blockade of telomerase activity and tumor cell growth by the DPL lipofection of ribbon antisense to hTR. Oncogene 24: 6492-6501, 2005.
15. Choi YK, Moon IJ, Jung HK, Jang BC, Seo SI and Park JG: Prevention of tissue injury by ribbon antisense to TGF-β1 in the kidney. Int J Mol Med 15: 391-399, 2005.
16. Schwarze SR, Ho A, Vocero-Akbani A and Dowdy SF: In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285: 1569-1572, 1999.
17. Fulda S, Wick W, Weller M and Debatin KM: Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo. Nat Med 8: 808-815, 2002.
18. Vives E, Brodin P and Lebleu B: A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem 272: 16010-16017, 1997.
19. Eguchi A, Akuta T, Okuyama H, Senda T, Yokoi H, Inokuchi H, Fujita S, Hayakawa T, Takeda K, Hasegawa M and Nakanishi M: Protein transduction domain of HIV-1 Tat protein promotes efficient delivery of DNA into mammalian cells. J Biol Chem 276: 26204-26210, 2001.
20. Futaki S, Suzuki T, Ohashi W, Yagami T, Tanaka S, Ueda K and Sugiura Y: Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J Biol Chem 276: 5836-5840, 2001.
21. Torchilin VP, Rammohan R, Weissig V and Levchenko TS: TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc Natl Acad Sci USA 98: 8786-8791, 2001.
22. Zanta MA, Belguise-Valladier P and Behr JP: Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. Proc Natl Acad Sci USA 96: 91-96, 1999.
23. Ludtke JJ, Zhang G, Sebestyen MG and Wolff JA: A nuclear localization signal can enhance both the nuclear transport and expression of I kb DNA. J Cell Sci 112: 2033-2041, 1999.
24. Derossi D, Calvet S, Trembleau A, Brunissen A, Chassaing G and Prochiantz A: Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. J Biol Chem 271: 18189-18193, 1996.
25. Dokka S, Toledo D, Shi X, Ye I and Rojanasakul Y: High-efficiency gene transfection of macrophages by lipoplexes. Int J Pharm 206: 97-104, 2000.
26. Sorgi FL, Bhattacharya S and Huang L: Protamine sulfate enhances lipid-mediated gene transfer. Gene Ther 4: 961-968, 1997.
27. Bharath MM, Chandra NR and Rao MRS: Prediction of an HMG-box fold in the C-terminal domain of histone H1: insights into its role in DNA condensation. Proteins 49: 71-81, 2002.
28. Nakamura T, Ueno T, Sakamoto M, Sakata R, Torimura, T, Hashimoto O, Ueno H and Sata M: Suppression of transforming growth factor-beta results in upregulation of transcription of regeneration factors after chronic liver injury. J Hepatol 41: 974-982, 2004.
29. Arias M, Lahme B, Van de Leur E, Gressner AM and Weiskirchen R: Adenoviral delivery of an antisense RNA complementary to the 3′ coding sequence of transforming growth factor-beta1 inhibits fibrogenic activities of hepatic stellate cells. Cell Growth Differ 13: 265-273, 2002.
30. Arias M, Sauer-Lehnen S, Treptau J, Janoschek N, Theuerkauf I, Buettner R, Gressner AM and Weiskirchen R: Adenoviral expression of a transforming growth factor-betal antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats. BMC Gastroenterol 3: 29, 2003.
31. Ramadori G and Saile B: Portal tract fibrogenesis in the liver. Lab Invest 84: 153-159, 2004.
32. Forbes SJ, Russo FP, Rey V, Burra. P, Rugge M, Wright NA and Alison MR: A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroenterology 126: 955-963, 2004.
33. Friedman SL, Roll FJ, Boyles J and Bissell DM: Hepatic lipocytes: the principal collagen-producing cells of normal rat liver. Proc Natl Acad Sci USA 82: 8681-8685, 1985.
34. Alcolado R, Arthur MJ and Iredale JP: Pathogenesis of liver fibrosis. Clin Sci 92: 103-112, 1997.
35. Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Pawley S, Hovell C and Arthur MJ: Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest 102: 538-549, 1998.
36. Hammel P, Couvelard A, O'Toole D, Ratouis A, Sauvanet A, Flejou JF, Degott C, Belghiti J, Bernades P, Valla D, Ruszniewski P and Levy P: Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct. N Engl J Med 344: 418-423, 2001.
37. Issa R, Zhou X, Constandinou CM, Fallowfield J, Millward-Sadler H, Gaca MD, Sands E, Suliman I, Trim N, Knorr A, Arthur MJ, Benyon RC and Iredale JP: Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking. Gastroenterology 126: 1795-1808, 2004.
38. Pinzani M, Gesualdo L, Sabbah GM and Abboud HE: Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. J Clin Invest 84: 1786-1793, 1989.
39. Borkham-Karnphorst E, Stoll D, Gressner AM and Weiskirchen R: Antisense strategy against PDGF B-chain proves effective in preventing experimental liver fibrogenesis. Biochem Biophys Res Commun 321: 413-423, 2004.
40. Schnabl B, Kweon YO, Frederick JP, Wang XF, Rippe RA and Brenner DA: The role of Smad3 in mediating mouse hepatic stellate cell activation. Hepatology 34: 89-100, 2001.
41. Dooley S, Hamzavi J, Breitkopf K, Wiercinska E, Said HM, Lorenzen J, Ten Dijke P and Gressner AM: Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gastroenterology 125: 178-191, 2003.